Literature DB >> 12867640

Preferential nuclear localization of the human papillomavirus type 16 E6 oncoprotein in cervical carcinoma cells.

Murielle Masson1, Colette Hindelang2, Annie-Paule Sibler1, Georges Schwalbach1, Gilles Travé1, Etienne Weiss1.   

Abstract

The E6 protein of the high-risk human papillomavirus type 16 (HPV-16) is involved in the tumorigenesis of human cervical cells by targeting numerous cellular proteins. We characterized new anti-E6 monoclonal antibodies and used them for precise localization of the E6 oncoprotein within carcinoma cells. Overexpressed E6 protein was predominantly detected in the nucleus of transiently transfected HaCaT cells. While mostly localized at the periphery of condensed chromatin, E6 was also associated with nuclear ribonucleoproteic ultrastructures and with some ribosomal areas in the cytoplasm of SiHa and CaSki cells. The chimeric beta-galactosidase-E6 protein expressed in transfected HeLa cells was essentially localized in the nuclear compartment. Together, these data indicate that the E6 sequence of HPV-16 may encode a nuclear localization signal. The preferential nuclear distribution of this viral oncoprotein in HPV-transformed cells correlates with its activities at the transcriptional level.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12867640     DOI: 10.1099/vir.0.18961-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  12 in total

1.  Involvement of nuclear export in human papillomavirus type 18 E6-mediated ubiquitination and degradation of p53.

Authors:  Deborah Stewart; Anirban Ghosh; Greg Matlashewski
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

2.  p53 degradation activity, expression, and subcellular localization of E6 proteins from 29 human papillomavirus genotypes.

Authors:  Thibault Mesplède; David Gagnon; Fanny Bergeron-Labrecque; Ibrahim Azar; Hélène Sénéchal; François Coutlée; Jacques Archambault
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

3.  Solution structure analysis of the HPV16 E6 oncoprotein reveals a self-association mechanism required for E6-mediated degradation of p53.

Authors:  Katia Zanier; Abdellahi ould M'hamed ould Sidi; Charlotte Boulade-Ladame; Vladimir Rybin; Anne Chappelle; Andrew Atkinson; Bruno Kieffer; Gilles Travé
Journal:  Structure       Date:  2012-04-03       Impact factor: 5.006

4.  Gamma interferon-inducible protein 10 induces HeLa cell apoptosis through a p53-dependent pathway initiated by suppression of human papillomavirus type 18 E6 and E7 expression.

Authors:  Huifang M Zhang; Ji Yuan; Paul Cheung; David Chau; Brian W Wong; Bruce M McManus; Decheng Yang
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

5.  The ubiquitin-specific peptidase USP15 regulates human papillomavirus type 16 E6 protein stability.

Authors:  Robin M Vos; Jennifer Altreuter; Elizabeth A White; Peter M Howley
Journal:  J Virol       Date:  2009-06-24       Impact factor: 5.103

6.  GRIM-19 disrupts E6/E6AP complex to rescue p53 and induce apoptosis in cervical cancers.

Authors:  Ying Zhou; Ying Wei; Jing Zhu; Qingyuan Wang; Liang Bao; Yang Ma; Yu Chen; Dingqing Feng; Aijin Zhang; Jie Sun; Shreeram C Nallar; Keng Shen; Dhananjaya V Kalvakolanu; Weihua Xiao; Bin Ling
Journal:  PLoS One       Date:  2011-07-12       Impact factor: 3.240

7.  A novel intracellular antibody against the E6 oncoprotein impairs growth of human papillomavirus 16-positive tumor cells in mouse models.

Authors:  Carla Amici; Michela Visintin; Francesca Verachi; Francesca Paolini; Zulema Percario; Paola Di Bonito; Angela Mandarino; Elisabetta Affabris; Aldo Venuti; Luisa Accardi
Journal:  Oncotarget       Date:  2016-03-29

8.  Cidofovir selectivity is based on the different response of normal and cancer cells to DNA damage.

Authors:  Tim De Schutter; Graciela Andrei; Dimitri Topalis; Lieve Naesens; Robert Snoeck
Journal:  BMC Med Genomics       Date:  2013-05-23       Impact factor: 3.063

9.  Intracellular Analysis of the Interaction between the Human Papillomavirus Type 16 E6 Oncoprotein and Inhibitory Peptides.

Authors:  Christina Stutz; Eileen Reinz; Anja Honegger; Julia Bulkescher; Johannes Schweizer; Katia Zanier; Gilles Travé; Claudia Lohrey; Karin Hoppe-Seyler; Felix Hoppe-Seyler
Journal:  PLoS One       Date:  2015-07-07       Impact factor: 3.240

10.  Targeting endogenous nuclear antigens by electrotransfer of monoclonal antibodies in living cells.

Authors:  Guillaume Freund; Annie-Paule Sibler; Dominique Desplancq; Mustapha Oulad-Abdelghani; Marc Vigneron; Julian Gannon; Marc H Van Regenmortel; Etienne Weiss
Journal:  MAbs       Date:  2013-05-29       Impact factor: 5.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.